News

Bal Pharma Limited informed the National Stock Exchange of India Limited and BSE Limited that, based on a certificate received from its Registrar and Transfer Agent, MUFG Intime India Private Limited, the details of securities dematerialised/rematerialised during the quarter ended September 30, 2026, have been duly furnished to both stock exchanges within the prescribed time limit.

Bal Pharma Limited announced that its members approved the re-appointment of Ravindra Kumar Kothari as a director liable to retire by rotation and a change in his designation from Non-Executive Director to Whole-Time Director, designated as Executive Director, effective October 1, 2026. Additionally, Virupakshaya Himesh’s designation changed from Whole-Time Director to Non-Executive Director, also effective October 1, 2026, resulting in the reconstitution of the Nomination and Remuneration Committee and the Stakeholders’ Relationship Committee.

Bal Pharma Limited will close its trading window from October 1, 2026, until 48 hours after the announcement of its financial results for the second quarter ending September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Bal Pharma Ltd. announced the allotment of 10,00,000 warrants on a preferential basis to promoter Mr. Shailesh Siroya, for Rs 8,40,00,000, at an issue price of Rs 84 per warrant. The company received Rs 2,10,00,000, representing 25% of the total amount payable for the warrants, and the allotment was approved by the board on September 7, 2026. Each warrant is convertible into one equity share with a face value of Rs 10 and a premium of Rs 74, and can be exercised within 18 months from the allotment date.

Bal Pharma Limited has declared a final dividend of Rs. 1.20 per equity share, equivalent to 12% of the face value, for fiscal year 2025-26, with a record date of September 17, 2026. The company will pay the dividend on or after September 24, 2026, and tax will be deducted at source unless shareholders submit the necessary forms and documentation through MUFG Intime India Private Limited`s online facility or designated email addresses.